GlassScriptPhysician profile
Howard M Baruch
NPI 1023025236
$2,594.33
in general payments reported to CMS, 2019-2025
20 companies · $482 in 2025
The $482 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $72.90 · 2021: $359 · 2022: $106 · 2023: $142 · 2024: $1,236 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935 · Travel and Lodging: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.87 |
| Travel and Lodging | $925.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $968.48 | 2023-2024 | Excelsiusgps Robotic Navigation System, Distal Radius Plate |
| Zimmer Biomet Holdings, INC. | $343.47 | 2019-2025 | Persona |
| Ferring Pharmaceuticals INC. | $321.67 | 2019-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $131.64 | 2024 | Twistr, Truespan Orthocord, Healix Knotless Peek |
| Smith+Nephew, INC. | $121.08 | 2021 | |
| Stryker Corporation | $109.94 | 2023-2025 | Mako, Spy-Phi System |
| Kerecis Limited | $101.53 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $74.59 | 2019-2022 | |
| Abbott Laboratories | $57.76 | 2019 | |
| Sanofi-Aventis U.S. LLC | $54.03 | 2019-2021 | |
| Davol INC. | $50.22 | 2021 | |
| Linkbio Corp | $45.07 | 2025 | |
| Bioventus LLC | $39.24 | 2021-2022 | |
| Acera Surgical, INC. | $33.19 | 2025 | Restrata Wound Matrix |
| Electronic Waveform Lab, INC. | $32.39 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $28.18 | 2020 | |
| Orthofix Medical, INC. | $25.40 | 2025 | Physio-Stim |
| Dynasplint Systems INC. | $22.69 | 2024 | Dynasplint |
| Fidia Pharma USA INC. | $19.91 | 2023 | Hymovis, Triluron |
| Ibsa Pharma INC. | $13.85 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Baruch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.